Ross James Paul Joseph, Breau Rodney H, Vigil Humberto, Hickling Duane R, Angel Jonathan B, Mallick Ranjeeta, Cagiannos Ilias, Morash Christopher, Lavallée Luke T
Division of Urology, Department of Surgery, University of Ottawa, Ottawa, ON, Canada.
The Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Can Urol Assoc J. 2021 Dec;15(12):E644-E651. doi: 10.5489/cuaj.7158.
Infections are common after radical cystectomy. The objective of this study was to determine the association between antimicrobial prophylactic regimen and infection after radical cystectomy.
A retrospective cohort study was performed on patients who underwent radical cystectomy at one tertiary Canadian center between January 2016 and April 2020. Patients received antimicrobial prophylaxis based on surgeon preference (cefazolin/metronidazole or ampicillin/ciprofloxacin/metronidazole, or other). A univariable and multivariable logistic regression model was created to determine the association between antimicrobial regimen and postoperative infection within 30 days. The association between patient demographic factors, as well as preoperative and intraoperative variables and infection, was also determined. Infection characteristics, including type, timing, and antimicrobial susceptibilities were reported.
One hundred and sixty-five patients were included. Mean age was 69.8 years, 121 (73.3%) were male, and 72 (43.6%) received orthotopic neobladder diversion. Ninety-six patients (58%) received cefazolin/metronidazole prophylaxis, 50 (30%) received ampicillin/ciprofloxacin/metronidazole, and 19 (11.5%) received another regimen. Fifty-four patients (32.7%) developed a postoperative infection (surgical site infection or urinary tract infection). Surgical site infection occurred in 35 patients (21.2%) and urinary tract infection occurred in 34 (21.0%). There was no association between antimicrobial regimen and incidence of postoperative infection (surgical site infection or urinary tract infection, relative risk 0.99, 95% confidence interval 0.50-1.99).
The overall incidence of infection was 32.7% following radical cystectomy. The preoperative prophylactic antibiotic regimen used was not associated with incidence of postoperative infection.
根治性膀胱切除术后感染很常见。本研究的目的是确定抗菌预防方案与根治性膀胱切除术后感染之间的关联。
对2016年1月至2020年4月期间在加拿大一家三级中心接受根治性膀胱切除术的患者进行了一项回顾性队列研究。患者根据外科医生的偏好接受抗菌预防(头孢唑林/甲硝唑或氨苄西林/环丙沙星/甲硝唑,或其他)。建立了单变量和多变量逻辑回归模型,以确定抗菌方案与30天内术后感染之间的关联。还确定了患者人口统计学因素以及术前和术中变量与感染之间的关联。报告了感染特征,包括类型、时间和抗菌药敏情况。
纳入165例患者。平均年龄为69.8岁,121例(73.3%)为男性,72例(43.6%)接受原位新膀胱改道。96例患者(58%)接受头孢唑林/甲硝唑预防,50例(30%)接受氨苄西林/环丙沙星/甲硝唑,19例(11.5%)接受其他方案。54例患者(32.7%)发生了术后感染(手术部位感染或尿路感染)。35例患者(21.2%)发生手术部位感染,34例(21.0%)发生尿路感染。抗菌方案与术后感染发生率(手术部位感染或尿路感染,相对风险0.99,95%置信区间0.50-1.99)之间无关联。
根治性膀胱切除术后感染的总体发生率为32.7%。所使用的术前预防性抗生素方案与术后感染发生率无关。